Hsu, L. L., Sarnaik, S., Williams, S., Amilon, C., Wissmar, J., & Berggren, A. (2018). A dose‐ranging study of ticagrelor in children aged 3‐17 years with sickle cell disease: A 2‐part phase 2 study. Am J Hematol.

Hsu, Lewis L., Sharada Sarnaik, Suzan Williams, Carl Amilon, Jenny Wissmar, and Anders Berggren. "A Dose‐ranging Study of Ticagrelor in Children Aged 3‐17 Years With Sickle Cell Disease: A 2‐part Phase 2 Study." Am J Hematol 2018.

Hsu, Lewis L., et al. "A Dose‐ranging Study of Ticagrelor in Children Aged 3‐17 Years With Sickle Cell Disease: A 2‐part Phase 2 Study." Am J Hematol 2018.